LENZ Therapeutics, Inc. (LENZ) Current Reports & Earnings Releases
Upcoming
- 2026-11-04 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-02 | 8-K | Officer / Director Changes | SEC |
| 2026-06-12 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-24 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-12 | 8-K | Other Events | SEC |
| 2025-11-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-08 | 8-K | Other Events | SEC |
| 2025-09-30 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-31 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-10 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-15 | 8-K | Results of Operations, Reg FD Disclosure, Other Events | SEC |
| 2025-04-04 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-03-19 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-28 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-12 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-15 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-22 | 8-K | Acquisition or Disposition, Unregistered Sales, Item 3.03, Auditor Change, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Item 5.06, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-14 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-08 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-05 | 8-K | Other Events | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.